CORD-19:c654596857bce9cdd64ffc51842048643107348c / 13563-13756 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T126","span":{"begin":0,"end":193},"obj":"Sentence"},{"id":"T53635","span":{"begin":0,"end":193},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The world-wide problem of betalactam resistance (R) in Streptococcus pneumoniae (SP) has been complicated by increasing R to macrolides and some older fluoroquinolones (FQ) (ciprofloxacin CIP)."}

{"project":"Epistemic_Statements","denotations":[{"id":"T21","span":{"begin":0,"end":193},"obj":"Epistemic_statement"}],"text":"The world-wide problem of betalactam resistance (R) in Streptococcus pneumoniae (SP) has been complicated by increasing R to macrolides and some older fluoroquinolones (FQ) (ciprofloxacin CIP)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T126","span":{"begin":0,"end":193},"obj":"Sentence"}],"text":"The world-wide problem of betalactam resistance (R) in Streptococcus pneumoniae (SP) has been complicated by increasing R to macrolides and some older fluoroquinolones (FQ) (ciprofloxacin CIP)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T4","span":{"begin":69,"end":79},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"The world-wide problem of betalactam resistance (R) in Streptococcus pneumoniae (SP) has been complicated by increasing R to macrolides and some older fluoroquinolones (FQ) (ciprofloxacin CIP)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T13","span":{"begin":55,"end":79},"obj":"Disease"},{"id":"T14","span":{"begin":81,"end":83},"obj":"Disease"},{"id":"T15","span":{"begin":188,"end":191},"obj":"Disease"},{"id":"T61942","span":{"begin":55,"end":79},"obj":"Disease"},{"id":"T29234","span":{"begin":81,"end":83},"obj":"Disease"},{"id":"T36075","span":{"begin":188,"end":191},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0009459"},{"id":"A16","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0015364"},{"id":"A78689","pred":"mondo_id","subj":"T61942","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A24112","pred":"mondo_id","subj":"T29234","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A27756","pred":"mondo_id","subj":"T36075","obj":"http://purl.obolibrary.org/obo/MONDO_0009459"},{"id":"A23314","pred":"mondo_id","subj":"T36075","obj":"http://purl.obolibrary.org/obo/MONDO_0015364"}],"text":"The world-wide problem of betalactam resistance (R) in Streptococcus pneumoniae (SP) has been complicated by increasing R to macrolides and some older fluoroquinolones (FQ) (ciprofloxacin CIP)."}